Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload

Cardiology (Switzerland)

Volumn 128, Issue 3, 2014, Pages 285-292

  Xia, Jinggang ^a   Qu, Yang ^b   Shen, Hong ^c   Liu, Xiuhua ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Atorvastatin reload; Atrial fibrillation; Major adverse cardiac events; Noncardiac emergency surgery

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CLOPIDOGREL; PITAVASTATIN; PLACEBO; ROSUVASTATIN; SIMVASTATIN; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC ACID DERIVATIVE; TRIACYLGLYCEROL;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; EMERGENCY SURGERY; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYOPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS; RISK REDUCTION; SIDE EFFECT; TREATMENT DURATION; ATRIAL FIBRILLATION; DEATH, SUDDEN, CARDIAC; DISEASE FREE SURVIVAL; EMERGENCY TREATMENT; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROCEDURES; TREATMENT OUTCOME; ABSENCE OF SIDE EFFECTS; ACUTE APPENDICITIS; ACUTE CHOLECYSTITIS; ACUTE PANCREATITIS; CARDIOVASCULAR RISK; CHOLANGITIS; CHOLESTEROL BLOOD LEVEL; HEART ARRHYTHMIA; HEART MUSCLE REVASCULARIZATION; OUTCOME ASSESSMENT; PREOPERATIVE TREATMENT; SURVIVAL RATE; ULCER PERFORATION; UROLITHIASIS;

AGED; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; EMERGENCY TREATMENT; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LENGTH OF STAY; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PYRROLES; TREATMENT OUTCOME;

EID: 84901736790     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000362593     Document Type: Article

References (27)

1. Mangano DT: Perioperative cardiac morbidity. Anesthesiology 1990; 72:153-184.
2. Fleisher LA, Beckman JA, Brown KA, et al: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for non-cardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418-e499.
3. Steg PG, James SK, Atar D, et al: ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619.
4. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr: 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angi-na/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 123:e426-e579.
5. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO: 2009 Focused Updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: 2271-2306.
6. Durazzo AE, Machado FS, Ikeoka DT, De Ber-noche C, Monachini MC, Puech-Leao P, Car-amelli B: Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39: 967-975.
7. O'Neil-Callahan K, Katsimaglis G, Tepper MR, Ryan J, Mosby C, Ioannidis JP, Danias PG: Statins decrease perioperative cardiac complications in patients undergoing non-cardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 2005; 45:336-342.
8. Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, Verhagen HJ, Khan NA, Dunkelgrun M, Bax JJ, Poldermans D: Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009; 361:980-989.
9. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G: Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114:1455-1461.
10. Uettwiller-Geiger D, Wu AH, Apple FS, Jevans AW, Venge P, Olson MD, Darte C, Woodrum DL, Roberts S, Chan S: Multi-center evaluation of an automated assay for troponin I. Clin Chem 2002; 48:869-876.
11. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
12. Thygesen K, Alpert JS, Jaffe AS, et al: Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60:1581-1598.
13. Di SG, Patti G, Pasceri V, Gaspardone A, Col-onna G, Montinaro A: Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol 2009; 54:558-565.
14. Go AS, Mozaffarian D, Roger VL, et al: Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127:e6-e245.
15. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA: Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996; 57:37-44.
16. Cohen MC, Aretz TH: Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999; 8:133-139.
17. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Man-gano DT: A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291:1720-1729.
18. Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA: Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005; 128(suppl 2):9S-16S.
19. Sadowitz B, Maier KG, Gahtan V: Basic science review: statin therapy. I. The pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg 2010; 44:241-251.
20. Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters DD: Determinants of residual risk in secondary prevention patients treated with high-versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation 2012; 125:1979-1987.
21. Hahn JY, Kim HJ, Choi YJ, Jo SH, Kim HJ, Lee S, Ahn KJ, Song YB, Choi JH, Choi SH, Choi YJ, Lee KH, Lee SH, Gwon HC: Effects of ator-vastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J 2011; 162: 1026-1033.
22. Nafasi L, Rahmani R, Shafiee A, Salari A, Ab-dollahi A, Meysamie A: Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction? Curr Med Res Opin 2014; 30:381-386.
23. Guarini G, Marzilli M: Defining the role of high-dose statins in PCI. Am J Cardiovasc Drugs 2013; 13:189-197.
24. Dougherty PJ, Arora RR: Utility of early high dose statins in acute coronary syndrome. Am J Ther 2012; 19:369-376.
25. Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G: Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007; 49:1272-1278.
26. Tikkanen MJ, Fayyad R, Faergeman O, Ols-son AG, Wun CC, Laskey R, Kastelein JJ, Holme I, Pedersen TR: Effect of intensive lip-id lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels. Int J Cardiol 2013; 168:3846-3852.
27. Liu Y, Su Q, Li L: Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials. Clin Cardiol 2013; 36:E41-E48.